65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Ended Awarded Last action
- Contract number
- 36F79721D0239
- Awardee
-
Travere Therapeutics, Inc. UEI JUBZMHK84S36
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 43
Award facts
- Opportunity
-
- MSQS0A03R8 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $14,970,593.10
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs awarded Travere Therapeutics, Inc. a multiple-award Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs on September 15, 2021, with a ceiling value of $14,970,593.10 and an ultimate completion date of September 14, 2026. This contract, funded through Veterans Integrated Service Network 12 and administered as a civilian procurement without set-aside designations, establishes Travere as an authorized supplier on the General Services Administration's Pharmaceuticals and Drugs schedule. The contract encompasses Travere's complete portfolio of rare disease medications, including Thiola (tiopronin) for cystinuria and kidney disorders, Filspari for kidney conditions, Sparsentan for rare kidney diseases, Cholbam (chenodeoxycholic acid) for primary bile acid synthesis disorders and cholestatic liver conditions, and Chenodal (chenodiol) for gallstone prevention. Primary performance locations are San Diego, California, with supplementary operations in Foster City, California, Monroeville, Pennsylvania, and Bartlett, Tennessee. Travere serves as the prime contractor with no identified subcontracting relationships.
Under this master contract vehicle, multiple Veterans Integrated Service Networks issue delivery orders across the Veterans Health Administration system to procure the specialized pharmaceuticals required to support veteran healthcare services. A representative sample of delivery orders documented from October 2021 through February 2026 demonstrates consistent procurement activity, with individual delivery orders ranging from approximately $7,000 to $131,523.01, primarily for Thiola 100 milligram tablets, which represents the company's most frequently ordered product. Complementing this Federal Supply Schedule contract, Travere also holds a single-award Blanket Purchase Agreement valued at $25 million, expiring September 14, 2026, specifically designated for pre-negotiated pricing on Thiola and Cholbam. The contract structure enables the Veterans Health Administration to maintain supply chain efficiency and cost predictability for critical rare disease medications while serving the healthcare needs of over 9 million enrolled veterans across multiple integrated service networks.
Task orders
Show all 43
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79721A0022 | National Acquisition Center (VA) | $25,000,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 16
Quick answers
Who was awarded contract 36F79721D0239?
36F79721D0239 was awarded to Travere Therapeutics, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 15, 2021.
How much is contract 36F79721D0239 worth?
36F79721D0239's own ceiling is $14,970,593.
How many orders have been placed under contract 36F79721D0239?
43 orders have been placed under 36F79721D0239, the latest on August 5, 2026.
Who can order from contract 36F79721D0239?
36F79721D0239 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79721D0239 part of a contract vehicle?
Yes. 36F79721D0239 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79721D0239 competed?
The extent of competition for 36F79721D0239 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV